In vitro competitive inhibition of plasma cholinesterase by cocaine: normal and variant genotypes

J Toxicol Clin Toxicol. 1996;34(1):77-81. doi: 10.3109/15563659609020237.

Abstract

Objective: To determine the inhibitory constant, Ki, of cocaine for a number of the different genetic variants of human plasma cholinesterase.

Design: In vitro analysis of plasma cholinesterase activity in the presence of cocaine as a competitive inhibitor.

Methods: Six normal (UU) control sera and seven sera with the following plasma cholinesterase genotypes were assayed: AA, UA, AS, UF, US, AF and SS. Plasma cholinesterase activity was determined in the samples by colorimetric measurement of propionylthiocholine metabolism over a range of concentrations. Competitive activities were then determined in the presence of varying concentrations of cocaine. Double reciprocal plots (1/v vs 1/S) were used to calculate Km and Vmax for propionylthiocholine, and Ki for cocaine for each genotype.

Results: The variant forms of the plasma cholinesterase had high cocaine Ki values--all were approximately ten times greater than the Ki for normal plasma cholinesterase.

Conclusions: Since the inhibitory constant is an indirect measure of an enzyme's affinity for a competing substrate, a high Ki for cocaine at recreational or therapeutic concentrations would translate into a longer in vivo half-life. Our results support the growing evidence that low plasma cholinesterase activity predisposes to cocaine toxicity.

MeSH terms

  • Cholinesterase Inhibitors / pharmacology*
  • Cholinesterases / blood
  • Cholinesterases / drug effects*
  • Cholinesterases / genetics
  • Cocaine / metabolism
  • Cocaine / pharmacology*
  • Genetic Variation*
  • Genotype
  • Humans
  • Narcotics / metabolism
  • Narcotics / pharmacology*

Substances

  • Cholinesterase Inhibitors
  • Narcotics
  • Cholinesterases
  • Cocaine